The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
D016915:AIDS Vaccines; D035843:Biomedical Research; D014943:Global Health; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007391:International Cooperation
D016915:AIDS Vaccines
Curr Mol Med. 2003 May;3(3):209-16
12699358
Immunol Rev. 2004 Jun;199:227-50
15233738
AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1453-61
11054258
J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):184-90
11832690
Nat Med. 2003 Jul;9(7):839-43
12835701
J Med Primatol. 2002 Aug;31(4-5):237-56
12390546
Nature. 2003 Mar 20;422(6929):307-12
12646921
Lancet. 2001 Apr 14;357(9263):1149-53
11323041
Science. 2003 Jun 27;300(5628):2036-9
12829768
Nat Med. 2004 Aug;10(8):769-71
15286768
J Virol. 2004 Jul;78(13):7069-78
15194783
Nat Med. 2004 Mar;10(3):221-3
14991035
Science. 2002 May 24;296(5572):1439-43
12029127
J Med Primatol. 2003 Aug;32(4-5):201-10
14498980
Nat Immunol. 2004 Mar;5(3):233-6
14985706
Annu Rev Med. 2002;53:207-21
11818471
Nature. 2002 Jan 17;415(6869):331-5
11797011
J Immunol. 2004 May 15;172(10):6290-7
15128818
AIDS Rev. 2003 Oct-Dec;5(4):245-52
15012003
Science. 2004 Mar 26;303(5666):2019-22
15044802
Nat Med. 2004 Aug;10(8):806-10
15286782
Science. 2004 Jun 18;304(5678):1728
15205499
J Virol. 2002 Oct;76(20):10147-54
12239289
Lancet. 2004 Jul 3-9;364(9428):10-1
15234837
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3712-6
11880605
J Infect Dis. 2003 Apr 1;187(7):1038-45
12660917